• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Google Searches for Thyroid Eye Disease After Regulatory Approval of Teprotumumab.监管批准特普妥单抗后对甲状腺眼病的谷歌搜索。
JAMA Ophthalmol. 2022 Jun 1;140(6):639-642. doi: 10.1001/jamaophthalmol.2022.1000.
2
Teprotumumab and the Evolving Therapeutic Landscape in Thyroid Eye Disease.特罗特单抗与甲状腺眼病的治疗新进展。
J Clin Endocrinol Metab. 2022 Aug 8;107(Suppl_1):S36-S46. doi: 10.1210/clinem/dgac168.
3
Teprotumumab: A Review in Thyroid Eye Disease.特罗特单抗:甲状腺眼病治疗的研究进展。
Drugs. 2022 Nov;82(17):1663-1670. doi: 10.1007/s40265-022-01804-1. Epub 2022 Nov 23.
4
A Paradigm Shift in the Management of Thyroid Eye Disease How Teprotumumab Has Changed the Therapeutic Interface.甲状腺眼病管理模式的转变:特普瑞单抗如何改变治疗界面
J Neuroophthalmol. 2022 Mar 1;42(1):26-34. doi: 10.1097/WNO.0000000000001515.
5
Teprotumumab (Tepezza): from the discovery and development of medicines to USFDA approval for active thyroid eye disease (TED) treatment.特普替尼单抗(特泽萨):从药物的发现和开发到获得美国食品药品监督管理局批准用于治疗活动性甲状腺眼病(TED)。
Int Ophthalmol. 2021 Apr;41(4):1549-1561. doi: 10.1007/s10792-021-01706-3. Epub 2021 Jan 22.
6
Teprotumumab: Interpreting the Clinical Trials in the Context of Thyroid Eye Disease Pathogenesis and Current Therapies.特罗特单抗:从甲状腺眼病发病机制和现有疗法的角度解读临床试验。
Ophthalmology. 2021 Nov;128(11):1627-1651. doi: 10.1016/j.ophtha.2021.04.024. Epub 2021 Apr 28.
7
Impact of Teprotumumab on Clinical Practice in Thyroid Eye Disease.特罗特单抗对甲状腺眼病临床实践的影响。
Endocr Pract. 2024 Oct;30(10):937-942. doi: 10.1016/j.eprac.2024.06.010. Epub 2024 Jun 25.
8
Early Experience With the Clinical Use of Teprotumumab in a Heterogenous Thyroid Eye Disease Population.特罗特单抗在异质性甲状腺眼病患者中的临床应用早期经验。
Ophthalmic Plast Reconstr Surg. 2021;37(6):583-591. doi: 10.1097/IOP.0000000000001959.
9
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.替普罗珠单抗在长期甲状腺眼病及再治疗中的疗效、安全性和持久性:OPTIC-X研究
Ophthalmology. 2022 Apr;129(4):438-449. doi: 10.1016/j.ophtha.2021.10.017. Epub 2021 Oct 21.
10
Objective Diplopia Outcomes for Patients Treated With Teprotumumab for Thyroid Eye Disease.目的:甲状腺眼病患者接受替普瑞酮治疗的复视结局。
J Neuroophthalmol. 2024 Mar 1;44(1):80-86. doi: 10.1097/WNO.0000000000002001. Epub 2023 Sep 21.

引用本文的文献

1
Changes in Internet Search Behavior After a Direct-to-Consumer Advertising Campaign for Faricimab-svoa.法西单抗-svoa直接面向消费者的广告活动后互联网搜索行为的变化
J Vitreoretin Dis. 2024 Oct 7:24741264241288480. doi: 10.1177/24741264241288480.
2
Google Trends-Assisted Analysis of the Readability, Accountability, and Accessibility of Online Patient Education Materials for the Treatment of AMD After US FDA Approval of Pegcetacoplan.谷歌趋势辅助分析美国食品药品监督管理局批准培西他科兰后在线患者教育材料在年龄相关性黄斑变性治疗方面的可读性、可问责性和可及性。
J Vitreoretin Dis. 2024 Apr 30;8(4):421-427. doi: 10.1177/24741264241250156. eCollection 2024 Jul-Aug.
3
Analyzing Google Search Trends for Migraine Surgery and Nurtec in Response to Public Announcements.分析谷歌针对偏头痛手术和Nurtec的搜索趋势以回应公开声明。
Plast Reconstr Surg Glob Open. 2024 Jul 18;12(7):e5996. doi: 10.1097/GOX.0000000000005996. eCollection 2024 Jul.
4
Postmarketing Safety Concerns of Teprotumumab: A Real-World Pharmacovigilance Assessment.替普罗珠单抗的上市后安全性问题:一项真实世界药物警戒评估。
J Clin Endocrinol Metab. 2024 Dec 18;110(1):159-165. doi: 10.1210/clinem/dgae417.
5
Google Search Trends to assess public interest in and concern about Vuity for treating presbyopia.利用谷歌搜索趋势评估公众对治疗老花眼的 Vuity 的兴趣和关注。
PLoS One. 2023 Oct 26;18(10):e0293066. doi: 10.1371/journal.pone.0293066. eCollection 2023.
6
Implications of Public Interest in Colonoscopy: Analysis of Google Trends Data From 12 European Countries.公众对结肠镜检查的关注影响:来自12个欧洲国家的谷歌趋势数据分析
Cureus. 2023 Jul 24;15(7):e42395. doi: 10.7759/cureus.42395. eCollection 2023 Jul.
7
Changes in digital healthcare search behavior during the early months of the COVID-19 pandemic: A study of six English-speaking countries.2019冠状病毒病大流行最初几个月期间数字医疗搜索行为的变化:一项对六个英语国家的研究。
PLOS Digit Health. 2023 May 1;2(5):e0000241. doi: 10.1371/journal.pdig.0000241. eCollection 2023 May.
8
The Effect of the COVID-19 Pandemic on Digital Health-Seeking Behavior: Big Data Interrupted Time-Series Analysis of Google Trends.新冠疫情对数字健康搜索行为的影响:谷歌趋势大数据中断时间序列分析。
J Med Internet Res. 2023 Jan 16;25:e42401. doi: 10.2196/42401.

监管批准特普妥单抗后对甲状腺眼病的谷歌搜索。

Google Searches for Thyroid Eye Disease After Regulatory Approval of Teprotumumab.

机构信息

David Geffen School of Medicine, University of California Los Angeles, Los Angeles.

University of Pennsylvania Perelman School of Medicine, Philadelphia.

出版信息

JAMA Ophthalmol. 2022 Jun 1;140(6):639-642. doi: 10.1001/jamaophthalmol.2022.1000.

DOI:10.1001/jamaophthalmol.2022.1000
PMID:35482336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9052105/
Abstract

IMPORTANCE

Given that direct-to-consumer advertising campaigns have the potential to both positively and negatively affect patient care, clinicians would benefit from being conscious of changes in public interest that result from such campaigns.

OBJECTIVE

To understand how direct-to-consumer advertising was associated with information-seeking behavior based on Google Trends.

DESIGN, SETTING, AND PARTICIPANTS: This descriptive cross-sectional study used Google Trends to examine relative search volumes for thyroid eye disease (TED) from January 1, 2004, to June 30, 2021, in the US. The data for this cross-sectional study were downloaded on October 17, 2021. This study included internet search engine queries originating within the US, as determined by Google Trends.

MAIN OUTCOMES AND MEASURES

Monthly changes in relative search volumes for the terms "thyroid eye disease," "Tepezza," and "teprotumumab."

RESULTS

From January 1, 2004, through June 30, 2019, searches for TED demonstrated a stable baseline level with a mean (SD) relative search volume of 1.78 (1.25). After US Food and Drug Administration approval of teprotumumab in January 2020, TED searches increased by 25%. After the manufacturer of teprotumumab ran its first national television commercial in December 2020, a 525% increase in TED searches was observed. After a second series of national television advertisements for teprotumumab in May 2021, TED searches increased by 640%.

CONCLUSIONS AND RELEVANCE

Findings of this cross-sectional study suggest that direct-to-consumer advertising campaigns for teprotumumab may have been associated with an increase in internet search traffic for TED. Google Trends may serve as a useful tool for measuring the influence of pharmaceutical advertising campaigns on information-seeking behavior in the public. Additional studies are warranted to determine how these changes in public interest correlate with clinical measures, such as referral patterns.

摘要

重要性

鉴于直接面向消费者的广告活动有可能对患者护理产生积极和消极的影响,临床医生应该意识到此类广告活动所导致的公众兴趣变化。

目的

了解直接面向消费者的广告如何通过 Google Trends 与信息搜索行为相关联。

设计、设置和参与者:这项描述性的横断面研究使用 Google Trends 来检查 2004 年 1 月 1 日至 2021 年 6 月 30 日期间,美国甲状腺眼病 (TED) 的相对搜索量。这项横断面研究的数据于 2021 年 10 月 17 日下载。本研究包括美国境内的互联网搜索引擎查询,这是由 Google Trends 确定的。

主要结果和措施

“甲状腺眼病”、“Tepezza”和“teprotumumab”术语的相对搜索量的每月变化。

结果

从 2004 年 1 月 1 日至 2019 年 6 月 30 日,TED 的搜索显示出稳定的基线水平,平均(SD)相对搜索量为 1.78(1.25)。2020 年 1 月美国食品和药物管理局批准 teprotumumab 后,TED 的搜索量增加了 25%。在 teprotumumab 的制造商于 2020 年 12 月播出其首个全国性电视广告后,TED 的搜索量增加了 525%。在 2021 年 5 月播出第二系列 teprotumumab 的全国性电视广告后,TED 的搜索量增加了 640%。

结论和相关性

这项横断面研究的结果表明,teprotumumab 的直接面向消费者的广告活动可能与互联网上 TED 的搜索流量增加有关。Google Trends 可能是衡量药品广告活动对公众信息搜索行为影响的有用工具。需要进一步的研究来确定这些公众兴趣的变化与临床指标(如转诊模式)如何相关。